Monthly Cost Comparison: Wegovy vs Mounjaro Switch Guide
Understanding the Monthly Cost When You Switch From Wegovy to Mounjaro
When considering whether you can switch from Wegovy to Mounjaro, monthly cost becomes a crucial factor in your decision-making process. Wegovy (semaglutide) and Mounjaro (tirzepatide) follow different pricing structures due to their distinct mechanisms—Wegovy targets GLP-1 receptors exclusively, while Mounjaro acts on both GIP and GLP-1 receptors as a dual agonist. Understanding these costs helps you budget effectively for your weight management journey. At EverydayMeds (GPhC #9012878), we provide transparent pricing for both treatments, ensuring you can make an informed comparison before discussing the switch with your prescriber.
The monthly cost considerations extend beyond the immediate price per pen, encompassing dose escalation timelines, maintenance phase expenses, and long-term treatment sustainability. Both treatments require gradual dose increases over several months, with different escalation schedules that impact your monthly expenditure. Whether you can switch from Wegovy to Mounjaro depends partly on your ability to manage these ongoing costs alongside your clinical response to treatment. Our pricing structure supports both treatment pathways, allowing flexibility should your prescriber recommend transitioning between therapies.
Wegovy Monthly Pricing Breakdown for UK Patients
Wegovy's monthly cost structure follows a clear escalation pattern, starting at £79.99 for the 0.25mg starter dose (weeks 1-4) when you apply discount code FIRST40 at checkout. The pricing progresses to £94.99 for 0.5mg (weeks 5-8), £99.99 for 1mg (weeks 9-12), and £139.99 for 1.7mg (weeks 13-16), before reaching the maintenance dose of 2.4mg at £209.99 monthly. This escalation ensures your body adjusts gradually while managing costs during the initial treatment phase. Returning customers benefit from code DOSE25, maintaining consistent savings throughout their treatment journey.
For patients considering longer-term commitment, our bundle options provide convenience and supply security without the need to place monthly orders. The Ultimate Stability Trio offers three months of 2.4mg maintenance supply for £649.99, ensuring uninterrupted treatment during the critical maintenance phase. These bundles eliminate the uncertainty of monthly ordering while providing the same high-quality, cold-chain delivery that maintains Wegovy's efficacy from our GPhC-registered pharmacy.
Clinical Evidence Supporting Your Switch From Wegovy to Mounjaro Decision
In clinical trials, patients taking Wegovy alongside diet and exercise experienced an average weight reduction of approximately 15% at 68 weeks in the STEP 1 trial, compared to 2.4% with placebo (Wilding et al., NEJM, 2021). The STEP programme demonstrated sustained efficacy across diverse populations, with STEP 5 showing maintained weight reduction of 15.2% at two years. These results provide a clinical baseline when considering whether you can switch from Wegovy to Mounjaro based on your individual response and goals.
Mounjaro's tirzepatide mechanism offers a different approach through dual GIP and GLP-1 receptor activation, which may provide alternative benefits for some patients. However, comparing trial results directly between the treatments requires careful consideration of different study designs, populations, and endpoints. Your prescriber can evaluate your individual response to Wegovy and determine whether switching to Mounjaro's dual mechanism might offer additional benefits for your specific circumstances.
How Wegovy Works in Your Weight Management Programme
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone to support weight management alongside a reduced-calorie diet and increased physical activity. This prescription-only medicine works by reducing appetite and promoting feelings of satiety after smaller meals, which may help you maintain the caloric deficit necessary for weight management. The mechanism targets brain appetite centres, potentially reducing food cravings and helping you stick to your nutrition plan. Unlike quick fixes, Wegovy supports sustainable lifestyle changes by making portion control feel more natural and manageable. The once-weekly injection schedule provides consistent hormone regulation, supporting steady progress throughout your weight management journey.
Streamlined Ordering Process for Both Treatment Options
Starting your assessment for either Wegovy or Mounjaro takes just three minutes through our online clinical questionnaire, designed to capture the essential information your prescriber needs for treatment evaluation. Our qualified prescribers review each assessment within three working days (or 24 hours with express service), ensuring thorough evaluation of your medical history and treatment suitability. Once approved, your medication ships via next-day delivery using specialist cold-chain packaging that maintains optimal temperature throughout transit. This temperature-controlled process preserves medication efficacy from our pharmacy to your door, regardless of weather conditions. The entire process from assessment to delivery typically completes within four working days, getting you started on your chosen treatment pathway quickly and safely.
Storage Considerations When You Switch From Wegovy to Mounjaro
Wegovy offers practical storage advantages that may influence your decision if you can switch from Wegovy to Mounjaro, particularly regarding travel and lifestyle flexibility. Wegovy maintains stability for up to six weeks at room temperature below 30°C once removed from the fridge, compared to Mounjaro's 21-day room temperature limit. The FlexTouch pen design provides consistent dosing accuracy throughout the escalation schedule, from 0.25mg starter through to 2.4mg maintenance dosing. Proper storage in your fridge at 2-8°C before first use ensures optimal efficacy, while the extended room temperature stability supports travel and busy lifestyles. This storage flexibility becomes particularly valuable during the maintenance phase when consistent weekly dosing is crucial for sustained results.
Cost Planning Strategies for Long-term Treatment Success
When evaluating whether you can switch from Wegovy to Mounjaro, developing a comprehensive cost strategy helps ensure treatment sustainability beyond the initial months. The maintenance phase represents your largest ongoing investment, with Wegovy's 2.4mg dose costing £209.99 monthly, totaling approximately £2,519.88 annually at full maintenance pricing. However, our DOSE25 discount code for returning customers provides ongoing savings that reduce this annual commitment significantly. Planning for this investment alongside your clinical goals helps establish realistic expectations for long-term treatment success.
Budget planning should also consider the possibility of treatment adjustments, including potential switches between therapies based on your clinical response and tolerance. Some patients find that starting with one treatment and potentially switching to another provides the optimal balance of efficacy and tolerability. Our pricing structure accommodates these clinical decisions, ensuring you can adapt your treatment plan without financial barriers limiting your options.
Expert Guidance for Your Treatment Decision
Both Wegovy and Mounjaro are available from EverydayMeds, and your prescriber can help determine which treatment aligns best with your clinical needs, lifestyle, and budget considerations. Our clinical team evaluates multiple factors including your medical history, previous treatment responses, and individual circumstances to recommend the most appropriate option. The decision of whether you can switch from Wegovy to Mounjaro involves careful assessment of your current treatment response, any side effects experienced, and your long-term weight management goals. This personalized approach ensures your treatment plan supports both immediate success and sustainable long-term results. We provide ongoing support throughout your treatment journey, whether you continue with Wegovy or transition to an alternative therapy under medical supervision. Start your clinical assessment today using code FIRST40 for new customers, and discover which treatment option offers the best value for your individual needs at https://everydaymeds.co.uk/collections/wegovy.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
